Literature DB >> 1704529

PR interval behavior during exercise: implications for physiological pacemakers.

R M Luceri1, S L Brownstein, L Vardeman, S Goldstein.   

Abstract

The relationship between heart rate response and the dynamic changes in the PR interval was assessed in 631 patients undergoing routine cardiac exercise tests for a variety of clinical indications. Patients were stratified into four subsets: nonmedicated normals (n = 437), patients on beta-antagonist agents (n = 118), those on antiarrhythmic agents alone (n = 61) and those with a clinical diagnosis of advanced (New York Heart Association [NYHA] Class III or IV) congestive heart failure. All patients were in stable sinus rhythm throughout the test. PR intervals were measured at rest, at mid-exercise and at peak exercise. Mean PR intervals shortened to a statistically significant degree in most subgroups. This effect was predominantly observed in the earlier stages of exercise. In patients with advanced heart failure, there was no statistically significant shortening of exercise PR intervals later in exercise, demonstrating a parallel with their relatively blunted heart rate response. These changes in exercise PR intervals suggest that implanted pacemaker algorithms may be constructed to maximize hemodynamic benefit in patients requiring physiological pacemakers.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1704529     DOI: 10.1111/j.1540-8159.1990.tb06878.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  2 in total

1.  Ventricular pacing: to pace or not to pace.

Authors:  Paul A Levine
Journal:  Europace       Date:  2010-01       Impact factor: 5.214

2.  Smoking Accelerates Atrioventricular Conduction in Humans Concordant with Increased Dopamine Release.

Authors:  Affan B Irfan; Claudia Arab; Andrew P DeFilippis; Pawel Lorkiewicz; Rachel J Keith; Zhengzhi Xie; Aruni Bhatnagar; Alex P Carll
Journal:  Cardiovasc Toxicol       Date:  2020-10-12       Impact factor: 3.231

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.